IDH2 and cancer: Activation of reductive TCA cycle metabolism of glutamine and glutamate via conversion to α-ketoglutarate by the glutamate dehydrogenase reaction and flux to citrate via IDH2 has been invoked as a pathway for synthesis of biomass in growing cancer cells [29–31].